Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMIGLUCERASE vs INAVOLISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IMIGLUCERASE vs INAVOLISIB: Safety Overview

Metric IMIGLUCERASE INAVOLISIB
Total FAERS Reports 2,564 188
Deaths Reported 322 6
Death Rate 12.6% 3.2%
Hospitalizations 549 60
Average Patient Age 36.4 yrs 62.1 yrs
% Female Patients 62.7% 99.4%
FDA Approval Date N/A Oct 10, 2024
Manufacturer Genzyme Corporation Genentech, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription